Journal of Diabetes

Papers
(The TQCC of Journal of Diabetes is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Lower urinary albumin‐to‐creatinine ratio predicted all‐cause and cardiovascular mortality in Chinese population with diabetes and prediabetes—The Shanghai Changfeng cohort study47
Association of methylation risk score with incident type 2 diabetes mellitus: A nested case–control study45
Issue Information31
30
29
Changes in dietary intake of aspartic acid during and after intermittent fasting correlate with an improvement in fasting glucose in overweight individuals28
Response to: Critical commentary on the association between thiazolidinedione use and dementia risk in patients with type 2 diabetes27
Brain Iron Deposition Alterations in Type 2 Diabetes Mellitus Patients With Mild Cognitive Impairment Based on Quantitative Susceptibility Mapping26
Associations of Tea Consumption With the Risk of All‐Cause and Cause‐Specific Mortality Among Adults With Type 2 Diabetes: A Prospective Cohort Study in China25
Temporal associations of diabetes‐related complications with health‐related quality of life decrements in Chinese patients with type 2 diabetes: A prospective study among 19 322 adults—Joint Asia Diab24
The serum creatinine to cystatin C to waist circumference ratios predicts risk for type 2 diabetes: A Chinese cohort study24
Issue Information22
Interventional metabology: A review of bariatric arterial embolization and endovascular denervation for treating metabolic disorders20
Transparent machine learning suggests a key driver in the decision to start insulin therapy in individuals with type 2 diabetes18
Variation of IgG N‐linked glycosylation profile in diabetic retinopathy17
Association of obesity under different metabolic status with adverse outcomes in patients with chronic myeloid leukemia: A retrospective cohort study16
How can we reach the target of glucose control in type 1 diabetes?16
Insights from basic adjunctive examinations of GCK‐MODY, HNF1A‐MODY, and type 2 diabetes: A systemic review and meta‐analysis15
Issue Information15
November 7–8, 2022, T1DX‐QI Learning Session, Journal of Diabetes Abstracts13
Author Index13
Glycemic treatment: Further concepts12
Issue Information12
Predictors of mortality in a multiracial urban cohort of persons with type 2 diabetes and novel coronavirus 1911
Mechanisms of bariatric surgery for weight loss and diabetes remission11
The mediation role of SOCS3 methylation in the effect of serum testosterone on type 2 diabetes11
Commentary on CDC data showing an increased risk for pediatric diabetes with COVID‐19 infection10
Autophagy in the retinal neurovascular unit: New perspectives into diabetic retinopathy10
Relationships between type 2 diabetes, cell dysfunction, and redox signaling: A meta‐analysis of single‐cell gene expression of human pancreatic α‐ and β‐cells10
Yogliptin monotherapy in type 2 diabetes: A 12‐week randomized, double‐blind, placebo‐controlled phase II study9
Association between the stress–hyperglycemia ratio and all‐cause mortality in community‐dwelling populations: An analysis of the National Health and Nutrition Examination Survey (NHANES) 199
The 2022 American Diabetes Association Meeting9
Issue Information9
9
Efficacy and safety of total pancreatectomy with islet autotransplantation: A clinical study in Japan9
Frederick Banting's observations leading to the potential for islet neogenesis without transplantation9
Impact on glucometric variables and quality of life of the advanced hybrid closed‐loop system in pediatric and adolescent type 1 diabetes9
Fatty acid β‐oxidation and mitochondrial fusion are involved in cardiac microvascular endothelial cell protection induced by glucagon receptor antagonism in diabetic mice9
Diabetes epidemiology: Analysis of trends over time9
Reflections on a successful hybrid type 1 diabetes summer camp in China during the COVID‐19 pandemic9
8
Exercise‐induced improvement of glycemic fluctuation and its relationship with fat and muscle distribution in type 2 diabetes8
8
T1D exchange quality improvement collaborative: Accelerating change through benchmarking and improvement science for people with type 1 diabetes8
A stratified analysis of a deep learning algorithm in the diagnosis of diabetic retinopathy in a real‐world study8
Effect of dipeptidyl peptidase‐4 inhibitor on the progression of coronary artery disease evaluated by computed tomography in patients receiving insulin therapy for type 2 diabetes mellitus8
A comparison of the stress hyperglycemia ratio, glycemic gap, and glucose to assess the impact of stress‐induced hyperglycemia on ischemic stroke outcome8
A study on the status of normoalbuminuric renal insufficiency among type 2 diabetes mellitus patients: A multicenter study based on a Chinese population8
Association of lactate dehydrogenase and diabetic retinopathy in US adults with diabetes mellitus7
miRNAs as biomarkers for diagnosis of type 2 diabetes: A systematic review7
Pedal medial arterial calcification in diabetic foot ulcers: A significant risk factor of amputation and mortality7
The performance of noninvasive indexes of adults in identification of nonalcoholic fatty liver disease in children7
Cardiovascular disease and risk of incident diabetes mellitus: Findings from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)7
Risks and benefits of vaccines in diabetes7
Closed loop insulin delivery–Opportunities and limitations7
Diabesity phenotype in relation to the incidence and resolution of nonalcoholic fatty liver disease: A prospective cohort study7
Association between serum LDL‐C concentrations and risk of diabetes: A prospective cohort study7
The 2023 WCIRDC: Obesity7
Chronic glycemic control influences the relationship between acute perioperative dysglycemia and perioperative outcome7
C3c deposition predicts worse renal outcomes in patients with biopsy‐proven diabetic kidney disease in type 2 diabetes mellitus6
Decreased in n‐3 DHA enriched triacylglycerol in small extracellular vesicles of diabetic patients with cardiac dysfunction6
Influence of impaired glucose tolerance alone and combined with metabolic syndrome on long‐term risk of cardiovascular events and mortality6
Healthy sleep score, acute myocardial infarction, and type 2 diabetes6
Commentary on “Factors associated with diabetic foot ulcers and lower limb amputations in type 1 and type 2 diabetes supported by real‐world data from the German/Austrian DPV registry”6
Clinical and genetic characteristics of maturity‐onset diabetes of the young type 13: A systematic review of the literature6
Assessment of community‐managed blood glucose control in patients with diabetes mellitus in Shenzhen, China6
Subsequent perinatal outcomes of pregnancy with two consecutive pregnancies with gestational diabetes mellitus: A population‐based cohort study6
The rising prevalence of type 2 diabetes among the youth in southern India—An ancillary analysis of the Secular TRends in DiabEtes in India (STRiDE‐I) study6
Major adverse cardiovascular events’ reduction and their association with glucose‐lowering medications and glycemic control among patients with type 2 diabetes: A retrospective cohort study using elec6
A Review of micro RNAs changes in T2DM in animals and humans6
Is fluoroscopy‐guided percutaneous bone biopsy of diabetic foot with suspected osteomyelitis worthwhile? A retrospective study6
Association between red cell distribution width/serum albumin ratio and diabetic kidney disease6
Exploring factors associated with self‐rated health in individuals with diabetes and its impact on quality of life: Evidence from the Survey of Health, Ageing, and Retirement in Europe6
Prevalence of associated renal risk in type 2 diabetes mellitus in the United Arab Emirates6
Impaired glucose tolerance is associated with enhanced postprandial pancreatic polypeptide secretion6
Pan‐risk factor for a comprehensive cardiovascular health management5
Relative contributions of fasting and postprandial glucose increments, glycemic variability, and non‐glycemic factors to HbA1c in individuals with type 1 diabetes5
What was new at the 2023 American Diabetes Association meeting?5
Estimated glucose disposal rate predicts the risk of diabetic peripheral neuropathy in type 2 diabetes: A 5‐year follow‐up study5
Clinical characteristics, treatment, and treatment switch after molecular‐genetic classification in individuals with maturity‐onset diabetes of the young: Insights from the multicenter real‐world 5
Issue Information5
Renal effects and safety between Asian and non‐Asian chronic kidney disease and type 2 diabetes treated with nonsteroidal mineralocorticoid antagonists5
A novel nonsense mutation c.747C>G in the NEUROD1 gene detected within a Chinese family affected by maturity‐onset diabetes of the young type 65
Corrigendum5
Associations between handgrip strength and skeletal muscle mass with all‐cause mortality and cardiovascular mortality in people with type 2 diabetes: A prospective cohort study of the UK Bi5
Clinical investigation of glucokinase activators for the restoration of glucose homeostasis in diabetes5
Protein pyrrole adducts are associated with elevated glucose indices and clinical features of diabetic diffuse neuropathies5
Association between serum β2‐microglobulin and left ventricular hypertrophy in patients with type 2 diabetes mellitus: A cross‐sectional study5
Ubiquitin‐conjugating enzyme E2 for regulating autophagy in diabetic cardiomyopathy: A mini‐review5
November 11, 2024, T1DX‐QI Learning Session, Journal of Diabetes Abstracts5
Diabetic neuropathy: A NRF2 disease?5
5
Comparison of six anthropometric measures in discriminating diabetes: A cross‐sectional study from the National Health and Nutrition Examination Survey5
Issue Information4
4
Precision nutrition for gut microbiome and diabetes research: Application of nutritional n‐of‐1 clinical trials4
Presentations at the 81st scientific sessions of the American Diabetes Association (ADA), Part 14
4
Should glucagon‐like peptide‐1 receptor agonist treatment be withheld in preoperative management?4
Effect of sodium‐glucose cotransporter 2 inhibitors on the rate of decline in kidney function: A systematic review and meta‐analysis4
Sex differences in the risk of arterial stiffness among adults with different glycemic status and modifications by age4
Gut microbiota, serum metabolites, and lipids related to blood glucose control and type 1 diabetes4
The mediating role of gestational diabetes mellitus in the associations of maternal prepregnancy body mass index with neonatal birth weight4
Factors associated with diabetic foot ulcers and lower limb amputations in type 1 and type 2 diabetes supported by real‐world data from the German/Austrian DPV registry4
November 14–15, 2023, T1DX‐QI Learning Session, Journal of Diabetes Abstracts4
4
CircMAP3K5 promotes cardiomyocyte apoptosis in diabetic cardiomyopathy by regulating miR‐22‐3p/DAPK2 Axis4
Issue Information4
Assessing and predicting type 2 diabetes risk with triglyceride glucose‐body mass index in the Chinese nondiabetic population—Data from long‐term follow‐up of Da Qing IGT and Diabetes Study4
Comparison of medical resources and costs among patients with coronary heart disease and impaired glucose tolerance in the Acarbose Cardiovascular Evaluation trial4
Relationship between creatinine to body weight ratios and diabetes mellitus: A Chinese cohort study4
3
Do SGLT‐2 inhibitors exhibit similar cardiovascular benefit in patients with heart failure with reduced or preserved ejection fraction?3
Overview of oxidative stress and inflammation in diabetes3
Protective effects of nattokinase against microvasculopathy and neuroinflammation in diabetic retinopathy3
Low‐dose colchicine in type 2 diabetes with microalbuminuria: A double‐blind randomized clinical trial3
The potential of β‐cell growth promotion, continued3
3
Issue Information3
3
3
The association between age at diagnosis of type 2 diabetes and albuminuria in Chinese adults: A nationwide population study3
Diabetes update: What's new, what's interesting3
Stratum corneum hydration levels are negatively correlated with HbA1c levels in the elderly Chinese3
3
Potential mechanisms of metabolic reprogramming induced by ischemia–reperfusion injury in diabetic myocardium3
Glucagon‐like peptide‐1 receptor agonists and kidney outcomes3
Commentary on the T1D Exchange Quality Improvement Collaborative Learning Session November 2024 abstracts3
The journal of diabetes is adopting open access3
Positive additive interaction effects of age, sex, obesity, and metabolic syndrome on left ventricular dysfunction3
3
Correlation of ACR and TcPO2 in diabetic kidney disease patients: A pilot study3
The WCIRDC 2023: Concepts of insulin resistance3
Pediatric diabetes update3
Presentations at the 81st scientific sessions of the American Diabetes Association, part 23
Learning by reading: A review of recent diabetes articles3
Delayed diagnosis of diabetic ketoacidosis and associated mortality during the COVID‐19 pandemic3
Issue Information3
Simplicity: The Ultimate Sophistication in Managing Type 2 Diabetes With Severe Hyperglycemia3
The association of ideal cardiovascular health and its change with subclinical atherosclerosis according to glucose status: A prospective cohort study3
Association between coffee consumption and metabolic syndrome: A cross‐sectional and Mendelian randomization study3
Issue Information3
Issue Information3
Diagnostic biomarker for type 2 diabetic peripheral neuropathy via comprehensive bioinformatics analysis3
Issue Information3
Sleeve gastrectomy improved microvascular phenotypes from obesity cohort, detected with optical coherence tomography angiography3
Sex differences in prognostic role of fasting glucose, Oral glucose tolerance, and HbA1c in diabetic cardiovascular disease3
Rationale for glycemic control to improve cardiovascular outcome: Lessons from east and west3
Issue Information3
Postload glucose spike but not fasting glucose determines prognosis after myocardial infarction in patients without known or newly diagnosed diabetes3
3
Novel approaches to the treatment of type 1 diabetes3
A novel heterozygous mutation in the SLC5A2 gene causing severe glycosuria, mild failure to thrive, and subclinical hypoglycemia3
Issue Information3
0.1365339756012